1. Home
  2. MIST vs ZVIA Comparison

MIST vs ZVIA Comparison

Compare MIST & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • ZVIA
  • Stock Information
  • Founded
  • MIST 2003
  • ZVIA 2007
  • Country
  • MIST Canada
  • ZVIA United States
  • Employees
  • MIST N/A
  • ZVIA N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • ZVIA Beverages (Production/Distribution)
  • Sector
  • MIST Health Care
  • ZVIA Consumer Staples
  • Exchange
  • MIST Nasdaq
  • ZVIA Nasdaq
  • Market Cap
  • MIST 163.2M
  • ZVIA 193.4M
  • IPO Year
  • MIST N/A
  • ZVIA 2021
  • Fundamental
  • Price
  • MIST $2.61
  • ZVIA $2.69
  • Analyst Decision
  • MIST Strong Buy
  • ZVIA Buy
  • Analyst Count
  • MIST 3
  • ZVIA 5
  • Target Price
  • MIST $6.33
  • ZVIA $4.89
  • AVG Volume (30 Days)
  • MIST 2.8M
  • ZVIA 787.3K
  • Earning Date
  • MIST 11-12-2025
  • ZVIA 11-05-2025
  • Dividend Yield
  • MIST N/A
  • ZVIA N/A
  • EPS Growth
  • MIST N/A
  • ZVIA N/A
  • EPS
  • MIST N/A
  • ZVIA N/A
  • Revenue
  • MIST N/A
  • ZVIA $162,849,000.00
  • Revenue This Year
  • MIST N/A
  • ZVIA $6.44
  • Revenue Next Year
  • MIST N/A
  • ZVIA $6.68
  • P/E Ratio
  • MIST N/A
  • ZVIA N/A
  • Revenue Growth
  • MIST N/A
  • ZVIA 6.17
  • 52 Week Low
  • MIST $0.63
  • ZVIA $1.88
  • 52 Week High
  • MIST $2.75
  • ZVIA $4.99
  • Technical
  • Relative Strength Index (RSI)
  • MIST 74.94
  • ZVIA 59.59
  • Support Level
  • MIST $2.31
  • ZVIA $2.62
  • Resistance Level
  • MIST $2.49
  • ZVIA $2.78
  • Average True Range (ATR)
  • MIST 0.19
  • ZVIA 0.13
  • MACD
  • MIST 0.06
  • ZVIA 0.01
  • Stochastic Oscillator
  • MIST 95.50
  • ZVIA 69.12

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: